| 2025-12-11 |
详情>>
内部人交易：
Demski David M股份减少30000.00股
|
| 2025-10-30 |
详情>>
股本变动：
变动后总股本14855.02万股
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.81美元,归母净利润-1.22亿美元,同比去年增长5.56%
|
| 2025-10-30 |
财报披露：
美东时间 2025-10-30 盘后发布财报
|
| 2025-07-31 |
详情>>
业绩披露：
2025年中报每股收益-0.63美元,归母净利润-9305.1万美元,同比去年增长-4.35%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益-0.35美元,归母净利润-5190.7万美元,同比去年增长-7.04%
|
| 2025-04-25 |
股东大会：
将于2025-06-11召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve until the 2026 Annual Meeting of Stockholders;
2.To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;
3.To approve the amendment to our 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan;
4.To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our stock from 220,000,000 to 420,000,000 and to increase the number of authorized shares of our common stock from 200,000,000 to 400,000,000;
5.To approve, on an advisory basis, the compensation of our named executive officers;
6.To transact such other business as may be properly presented at the Annual Meeting and any adjournments or postponements thereof.
|
| 2025-02-26 |
详情>>
业绩披露：
2022年年报每股收益-1.46美元,归母净利润-1.51亿美元,同比去年增长-5.78%
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益-1.13美元,归母净利润-1.62亿美元,同比去年增长13.14%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.9美元,归母净利润-1.29亿美元,同比去年增长6.37%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益-0.63美元,归母净利润-8917.5万美元,同比去年增长6.04%
|
| 2024-07-31 |
详情>>
业绩披露：
2023年中报每股收益-0.83美元,归母净利润-9490.6万美元,同比去年增长-19.05%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.34美元,归母净利润-4849.5万美元,同比去年增长-11.41%
|
| 2024-04-26 |
股东大会：
将于2024-06-12召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve until the 2025 Annual Meeting of Stockholders;
2.To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may be properly presented at the Annual Meeting and any adjournments or postponements thereof.
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益-1.54美元,归母净利润-1.87亿美元,同比去年增长-23.36%
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.18美元,归母净利润-1.38亿美元,同比去年增长-18.07%
|
| 2023-04-28 |
股东大会：
将于2023-06-14召开股东大会
会议内容 ▼▲
- 1.To elect twelve directors to serve until the 2024 Annual Meeting of Stockholders.
2.To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 202.
3.To approve the amendment to our 2007 Employee Stock Purchase Plan to increase the number of shares reserved for issuance under the plan.
4.To approve the amendment to our 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan.
5.To approve, on an advisory basis, the compensation of our named executive officers.
6.To approve, on an advisory basis, the frequency of future stockholder votes to approve the compensation of our named executive officers.
7.To transact such other business as may be properly presented at the Annual Meeting and any adjournments or postponements thereof.
|
| 2022-04-28 |
股东大会：
将于2022-06-15召开股东大会
会议内容 ▼▲
- 1.To elect thirteen directors to serve until the 2023 Annual Meeting of Stockholders;
2.To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may be properly presented at the Annual Meeting and any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-06-16召开股东大会
会议内容 ▼▲
- 1.To elect twelve directors to serve until the 2022 Annual Meeting of Stockholders;
2.To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021;
3.To approve the amendment to our 2007 Employee Stock Purchase Plan to increase the number of shares reserved for issuance under the plan;
4.To approve, on an advisory basis, the compensation of our named executive officers;
5.To transact such other business as may be properly presented at the Annual Meeting and any adjournments or postponements thereof.
|
| 2020-04-28 |
股东大会：
将于2020-06-17召开股东大会
会议内容 ▼▲
- 1.to elect eleven persons to our Board of Directors;
2.to ratify the selection of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2020;
3.to approve the amendment to our 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan;
4.to approve, on an advisory basis, the compensation of our named executive officers.
|
| 2020-02-28 |
复牌提示：
2020-02-28 09:32:11 停牌，复牌日期 2020-02-28 09:42:12
|
| 2019-04-30 |
股东大会：
将于2019-06-12召开股东大会
会议内容 ▼▲
- 1.to elect ten persons to our Board of Directors;
2.to ratify the selection of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2019;
3.to approve the amendment to our 2007 Employee Stock Purchase Plan to increase the number of shares reserved for issuance under the plan;
4.to approve the amendment to our 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan;
5.to approve, on an advisory basis, the compensation of our named executive officers.
6.To transact such other business as may be properly presented at the Annual Meeting and any adjournments or postponements thereof.
|
| 2018-04-25 |
股东大会：
将于2018-05-17召开股东大会
会议内容 ▼▲
- 1.To elect eleven directors to serve until the 2019 annual meeting of stockholders;
2.To ratify the selection of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2018;
3.To approve the amendment of our 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan;
4.To approve, on an advisory basis, the compensation of our named executive officers;
5.To approve, as required by and in accordance with the listing rules of The Nasdaq Stock Market, the issuance of shares of our common stock (or securities convertible into or exercisable for common stock):
5a.representing more than 19.99% of our outstanding common stock or voting power in connection with: (i) the acquisition of SafeOp Surgical, Inc. by merger, (ii) our issuance of shares of Series B Convertible Preferred Stock and warrants in a private placement pursuant to a Securities Purchase Agreement dated March 8, 2018 with certain investors, and (iii) a Warrant Exercise Agreement dated March 8, 2018 with an existing warrant holder;
5b.in connection with the Securities Purchase Agreement to insiders at less than market prices;
5c.in connection with the above merger, the Securities Purchase Agreement, and the Warrant Exercise Agreement that could result in a Nasdaq Change of Control;
6.To transact such other business as may be properly presented at the Annual Meeting and any adjournments or postponements thereof.
|
| 2017-05-05 |
股东大会：
将于2017-06-15召开股东大会
会议内容 ▼▲
- 1.to elect seven persons to our Board of Directors;
2.to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2017;
3. to approve an amendment and restatement of our 2016 Equity Incentive Plan;
4. to approve an amendment and restatement of our 2007 Employee Stock Purchase Plan;
5. to approve, on an advisory basis, the compensation of our named executive officers;
6. to approve, on an advisory basis, the frequency of future stockholder votes to approve the compensation of our named executive officers;
7. to approve, as required by and in accordance with the listing rules of The NASDAQ Stock Market, the issuance of up to an aggregate of 17,525,972 shares of common stock issuable upon the conversion of outstanding shares of our Series A Convertible Preferred Stock and the exercise of outstanding warrants.
|
| 2016-08-24 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2016-06-22 |
股东大会：
将于2016-08-18召开股东大会
会议内容 ▼▲
- 1. to elect seven persons to our Board of Directors;
2. to approve the Alphatec Holdings, Inc. 2016 Equity Incentive Plan;
3. to approve an amendment to our Restated Certificate of Incorporation to effect a reverse stock split of our common stock, par value $0.0001 per share, at a ratio in the range of 1:4 to 1:12, such ratio to be determined by our Board of Directors to be effected in the sole discretion of the Board of Directors at any time within one year of the date of the Annual Meeting without further approval or authorization of our stockholders;
4. to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2016;
5. to approve the compensation of our named executive officers, as disclosed in this proxy statement.
|